Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene

FASEB Journal

Volumn 23, Issue 6, 2009, Pages 1766-1774

  Kalea, Anastasia Z ^a   Reiniger, Nina ^a   Yang, Hojin ^a   Arriero, Maria ^a   Schmidt, Ann Marie ^a   Hudson, Barry I ^a  

^a Columbia University ^*  (United States)

Author keywords

DNA cloning; mRNA; Protein evolution; Soluble receptor; Species specific splicing

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COMPLEMENTARY DNA; CYTOPLASM PROTEIN; DNA FRAGMENT; MEMBRANE PROTEIN; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; ISOPROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; ANIMAL; BIOLOGY; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TISSUE DISTRIBUTION;

MURINAE; MUS;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; COMPUTATIONAL BIOLOGY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; RECEPTORS, IMMUNOLOGIC; SEQUENCE HOMOLOGY, NUCLEIC ACID; TISSUE DISTRIBUTION;

EID: 67649344400     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-117739     Document Type: Article

References (41)

1. Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., and Soreq, H. (2005) Function of alternative splicing. Gene 344, 1-20
2. Lareau, L. F., Green, R. E., Bhatnagar, R. S., and Brenner, S. E. (2004) The evolving roles of alternative splicing. Curr. Opin. Struct. Biol. 14, 273-282
3. Xu, Q. and Lee, C. (2003) Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res. 31, 5635-5643 (Pubitemid 37441935)
4. Xing, Y., Xu, Q., and Lee, C. (2003) Widespread production of novel soluble protein isoforms by alternative splicing removal of transmembrane anchoring domains. FEBS Lett. 555, 572-578 (Pubitemid 37532613)
5. Nurtdinov, R. N., Neverov, A. D., Favorov, A. V., Mironov, A. A., and Gelfand, M. S. (2007) Conserved and species-specific alternative splicing in mammalian genomes. BMC Evol. Biol. 7, 249
6. Nurtdinov, R. N., Artamonova, I. I., Mironov, A. A., and Gelfand, M. S. (2003) Low conservation of alternative splicing patterns in the human and mouse genomes. Hum. Mol. Genet. 12, 1313-1320 (Pubitemid 36722611)
7. Hudson, B. I., Carter, A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., Grant, P. J., and Schmidt, A. M. (2007) Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22, 1572-1580 (Pubitemid 351656797)
8. Malherbe, P., Richards, J. G., Gaillard, H., Thompson, A., Diener, C., Schuler, A., and Huber, G. (1999) cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein. Brain Res. Mol. Brain Res. 71, 159-170
9. Yonekura, H., Yamamoto, Y., Sakurai, S., Petrova, R. G., Abedin, M. J., Li, H., Yasui, K., Takeuchi, M., Makita, Z., Takasawa, S., Okamoto, H., Watanabe, T., and Yamamoto, H. (2003) Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 370, 1097-1109 (Pubitemid 36399105)
10. Schlueter, C., Hauke, S., Flohr, A. M., Rogalla, P., and Bullerdiek, J. (2003) Tissue-specific expression patterns of the RAGE receptor and its soluble forms-a result of regulated alternative splicing? Biochim. Biophys. Acta 1630, 1-6
11. Park, I. H., Yeon, S. I., Youn, J. H., Choi, J. E., Sasaki, N., Choi, I. H., and Shin, J. S. (2004) Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol. Immunol. 40, 1203-1211 (Pubitemid 38210272)
12. Ding, Q., and Keller, J. N. (2005) Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain. Neurosci. Lett. 373, 67-72 (Pubitemid 39536223)
13. Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C. P., Elliston, K., Stern, D., and Shaw, A. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998-15004
14. Hofmann, M. A., Drury, S., Fu, C. F., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., Neurath, M. F., Slattery, T., Beach, D., McClary, J., Nagashima, M., Morser, J., Stern, D., and Schmidt, A. M. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for s100/calgranulin polypeptides. Cell 97, 889-901 (Pubitemid 29375048)
15. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., Morser, J., Stern, D., and Schmidt, A. M. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752-25761
16. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., and Schmidt, A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691 (Pubitemid 26282167)
17. Harashima, A., Yamamoto, Y., Cheng, C., Tsuneyama, K., Myint, K. M., Takeuchi, A., Yoshimura, K., Li, H., Watanabe, T., Takasawa, S., Okamoto, H., Yonekura, H., and Yamamoto, H. (2006) Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression. Biochem. J. 396, 109-115 (Pubitemid 43764502)
18. Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., and Schmidt, A. M. (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4, 1025-1031 (Pubitemid 28417334)
19. Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., Hofmann, M. A., Kislinger, T., Ingram, M., Lu, A., Tanaka, H., Hori, O., Ogawa, S., Stern, D., and Schmidt, A. M. (2000) Blockage of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405, 354-360 (Pubitemid 30337069)
20. Kislinger, T., Tanji, N., Wendt, T., Qu, W., Lu, Y., Ferran, L. J., Taguchi, A., Olson, K., Goova, M. T., Hofmann, M. A., Cataldegirmen, G., D'Agati, V., Pischetsrieder, M., Stern, D. M., and Schmidt, A. M. (2001) Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 21, 905-910 (Pubitemid 34168644)
21. -/- mice. J. Clin. Invest. 118, 183-194
22. Hudson, B. I., Wendt, T., Bucciarelli, L. G., Rong, L. L., Naka, Y., Yan, S. F., and Schmidt, A. M. (2005) Diabetic vascular disease: it's all the RAGE. Antioxid. Redox Signal. 7, 1588-1600 (Pubitemid 41767994)
23. Nagy, E., and Maquat, L. E. (1998) A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem. Sci. 23, 198-199 (Pubitemid 28302613)
24. Wain, H. M., Bruford, E. A., Lovering, R. C., Lush, M. J., Wright, M. W., and Povey, S. (2002) Guidelines for human gene nomenclature. Genomics 79, 464-470
25. Wendt, T., Harja, E., Bucciarelli, L., Qu, W., Lu, Y., Rong, L. L., Jenkins, D. G., Stein, G., Schmidt, A. M., and Yan, S. F. (2006) RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 185, 70-77 (Pubitemid 43117552)
26. Goova, M. T., Li, J., Kislinger, T., Qu, W., Lu, Y., Bucciarelli, L. G., Nowygrod, S., Wolf, B. M., Caliste, X., Yan, S. F., Stern, D. M., and Schmidt, A. M. (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am. J. Pathol. 159, 513-525 (Pubitemid 32751082)
27. Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., Stein, G., Bierhaus, A., Liliensiek, B., Arnold, B., Nawroth, P. P., Stern, D. M., D'Agati, V. D., and Schmidt, A. M. (2003) RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am. J. Pathol. 162, 1123-1137 (Pubitemid 36350658)
28. Falcone, C., Emanuele, E., D'Angelo, A., Buzzi, M. P., Belvito, C., Cuccia, M., and Geroldi, D. (2005) Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler. Thromb. Vasc. Biol. 25, 1032-1037 (Pubitemid 40627851)
29. Katakami, N., Matsuhisa, M., Kaneto, H., Matsuoka, T. A., Sakamoto, K., Nakatani, Y., Ohtoshi, K., Hayaishi-Okano, R., Kosugi, K., Hori, M., and Yamasaki, Y. (2005) Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. Diabetes Care 28, 2716-2721 (Pubitemid 43951165)
30. Basta, G., Sironi, A. M., Lazzerini, G., Del Turco, S., Buzzigoli, E., Casolaro, A., Natali, A., Ferrannini, E., Gastaldelli, A. (2006) Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. J. Clin. Endocrinol. Metab. 91, 4628-4634 (Pubitemid 44833448)
31. Koyama, H., Shoji, T., Yokoyama, H., Motoyama, K., Mori, K., Fukumoto, S., Emoto, M., Shoji, T., Tamei, H., Matsuki, H., Sakurai, S., Yamamoto, Y., Yonekura, H., Watanabe, T., Yamamoto, H., and Nishizawa, Y. (2005) Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25, 2587-2593 (Pubitemid 43732283)
32. Geroldi, D., Falcone, C., Emanuele, E., D'Angelo, A., Calcagnino, M., Buzzi, M. P., Scioli, G. A., and Fogari, R. (2005) Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J. Hypertens. 23, 1725-1729 (Pubitemid 41233433)
33. Emanuele, E., D'Angelo, A., Tomaino, C., Binetti, G., Ghidoni, R., Politi, P., Bernardi, L., Maletta, R., Bruni, A. C., and Geroldi, D. (2005) Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch. Neurol. 62, 1734-1736 (Pubitemid 41626671)
34. Galichet, A., Weibel, M., and Heizmann, C. W. (2008) Calcium-regulated intramembrane proteolysis of the RAGE receptor. Biochem. Biophys. Res. Commun. 370, 1-5
35. Raucci, A., Cugusi, S., Antonelli, A., Barabino, S. M., Monti, L., Bierhaus, A., Reiss, K., Saftig, P., and Bianchi, M. E. (2008) A soluble form of the receptor for advanced glycation end-products (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 22, 3716-3727
36. Brown, L. F., and Fraser, C. G. (2008) Assay validation and biological variation of serum receptor for advanced glycation end-products. Ann. Clin. Biochem. 45, 518-519
37. Hanford, L. E., Enghild, J. J., Valnickova, Z., Petersen, S. V., Schaefer, L. M., Schaefer, T. M., Reinhart, T. A., and Oury, T. D. (2004) Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J. Biol. Chem. 279, 50019-50024 (Pubitemid 39577812)
38. Lizotte, P. P., Hanford, L. E., Enghild, J. J., Nozik-Grayck, E., Giles, B. L., and Oury, T. D. (2007) Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung. BMC Dev. Biol. 7, 15 (Pubitemid 46426273)
39. Hudson, B. I., Kalea, A. Z., Arriero, M. D., Harja, E., Boulanger, E., D'Agati, V., and Schmidt, A. M. (2008) Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J. Biol. Chem. 283, 34457-34468
40. Huttunen, H. J., Fages, C., and Rauvala, H. (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924 (Pubitemid 129519445)
41. Sakaguchi, T., Yan, S. F., Yan, S. D., Belov, D., Rong, L. L., Sousa, M., Andrassy, M., Marso, S. P., Duda, S., Arnold, B., Liliensiek, B., Nawroth, P. P., Stern, D. M., Schmidt, A. M., and Naka, Y. (2003) Central role of RAGE-dependent neointimal expansion in arterial restenosis. J. Clin. Invest. 111, 959-972 (Pubitemid 36397472)